Basic population information
The mean age of the A+P group was 52 years (42.5, 59.0), which was higher than that of the azvudine and paxlovid groups (P=0.025). There were no significant differences in the sex composition among the three groups. In terms of comorbidities, there was no significant difference between the three groups in terms of comorbidity with hypertension and coronary artery disease; however, the paxlovid group had a higher proportion of comorbid diabetes than the other two groups (P=0.032). There were differences in the clinical typing of the novel coronavirus among the three groups, with the highest proportion of severe and critical cases in the A+P group (35.5 %). The basic patient profiles are shown in Table 1.